Heidi, a Melbourne, Australia-based healthcare AI company, has raised $65 million in a Series B round, at a $465 million valuation.
Investors
The round was led by Point72 Private Investments, with participation from Blackbird, Headline, and Latitude, bringing Heidi's total funding to nearly $100 million.
Point72 Private Investments is an institutional platform comprising Point72 Ventures, a multi-stage venture capital strategy, and Point72 Hyperscale, a private equity strategy leveraging AI to build and modernize market-leading companies. It offers asset management, equities, foreign exchange, research, investment strategies, financial planning, and investment advisory services.
Heidi Use of Funds
The company will use the new funding to expand its AI Care Partner platform globally, grow its workforce and offices in the USA, UK, and Canada, and strengthen clinician-led adoption in additional international markets, including France, Germany, Spain, Ireland, South Africa, Singapore, and Hong Kong.
About Heidi
Founded by Dr. Thomas Kelly, Heidi is building an AI care partner to expand clinical capacity by automating administrative work, documentation, form-filling, and task management. Used across emergency departments, general practice, and specialist clinics, its platform operates in 110 languages across 116 countries, with adoption spanning primary care networks, hospitals, and national healthcare systems. Partner deployments include collaborations with Modality Partnership, Cambridge University Hospitals NHS Foundation Trust, Beth Israel Lahey Health, MaineGeneral, Monash Health, and Queensland Health.
Funding Details
Company: Heidi
Raised: $65.0M USD
Round: Series B
Funding Date: October 2025
Lead Investor: Point72 Private Investments
Additional Investors: Blackbird, Headline, Latitude
Company Website: https://www.heidihealth.com/
Software Category: Healthcare AI / Clinical Productivity / Medical Automation
Source: https://www.heidihealth.com/blog/blog-heidi-series-b